by Margy MacMillan
ASTCT President Margy MacMillan highlights upcoming opportunities for education, collaboration, and professional growth, including the 2027 Tandem Meetings, Premier Awards, educational programs,...
by Alex Kadhim
Researchers identified ADGRG1 and CD86 as novel markers of tumor-reactive CD4+ T cells in solid tumors, enabling enrichment of neoantigen-specific lymphocytes for functional studies and...
by Alex Kadhim
A pooled analysis in advanced melanoma identifies stem-like and LAG-3-expressing CD8+ T cells, along with tumor-associated tertiary lymphoid structures, as key predictors of durable response to...
by Alex Kadhim
A new Blood study identifies recipient endothelial IFNγ-IRF1 signaling as a critical regulator of immune tolerance after allogeneic hematopoietic cell transplantation, promoting regulatory T-cell...
by Alex Kadhim
A multicenter Engraft Learning Health Network study reveals significant variation in chronic graft-versus-host disease screening practices after allogeneic hematopoietic cell transplantation,...
by Nucleus Staff
Incoming Transplantation and Cellular Therapy Editor-in-Chief David L. Porter, MD, shares his vision for the future of ASTCT’s official journal, discussing emerging advances in...